| Reference | Name | Unity | Provider | Aplication | Clonality | Host | Reactivity | Price | Tech.Sheet |
|---|---|---|---|---|---|---|---|---|---|
| Ab03804-23.0-BT | Anti-PD-1 [Anti-human PD-1 antibody] | 1 mg | Absolute Antibody | ELISA; Blocking; Inhibition | Human | Request Quotation | Request | ||
| Ab01022-2.3-BT | Anti-VEGF [G6-31] | 1 mg | Absolute Antibody | ELISA; crystallisation; block; SPR; IF | Mouse | Request Quotation | Request | ||
| Ab03832-10.0-BT | Anti-MUC1-C/ECD [8E1] | 1 mg | Absolute Antibody | ELISA; WB; FC | Human | Request Quotation | Request | ||
| Ab03826-1.1 | Anti-EGFR [EGFR-8] | 100 ug | Absolute Antibody | ELISA; WB; Inhibition | Human | Request Quotation | Request | ||
| Ab03825-23.0-BT | Anti-EGFR [ML66] | 1 mg | Absolute Antibody | Inhibition; FC; in vivo | Human | Request Quotation | Request | ||
| Ab03802-23.0-BT | Anti-VSTM5 [F03] | 1 mg | Absolute Antibody | FACS; ELISA | Human | Request Quotation | Request | ||
| Ab03796-1.1-BT | Anti-APP [2F9] | 1 mg | Absolute Antibody | ELISA; blocking | Human, Mouse | Request Quotation | Request | ||
| Ab03834-23.0 | Anti-CD98 [18-2a 7.1] | 100 ug | Absolute Antibody | FACS; SPR | Human | Request Quotation | Request | ||
| Ab03783-10.0-BT | Anti-Benzopyrene [22F12] | 1 mg | Absolute Antibody | ELISA | Other | Request Quotation | Request | ||
| Ab00846-10.3-BT | Anti-V(beta)3 TCR [JOVI.1] | 1 mg | Absolute Antibody | FACS; IHC; IF; IP | Human | Request Quotation | Request | ||
| Ab04028-3.3 | Anti-VEGFR-3 [ABDD073] | 100 ug | Absolute Antibody | ELISA; IHC; FC | Human | Request Quotation | Request | ||
| Ab03832-23.0-BT | Anti-MUC1-C/ECD [8E1] | 1 mg | Absolute Antibody | ELISA; WB; FC | Human | Request Quotation | Request | ||
| Ab03805-10.0 | Anti-PD-1 [6#] | 100 ug | Absolute Antibody | ELISA; blocking; SPR; inhibition | Human | Request Quotation | Request | ||
| Ab04035-10.3 | Anti-VEGFR-2 [AbAb-VEGFR-2] | 100 ug | Absolute Antibody | ELISA; SPR | Human | Request Quotation | Request | ||
| Ab00136-1.7-BT | Anti-V5 epitope tag [SV5-P-K] | 1 mg | Absolute Antibody | ELISA; IF; IHC-Fr; IP; RIA; WB | Paramyxovirus Simian Virus 5 | Request Quotation | Request | ||
| Ab03563-10.3 | Anti-VASA protein [1E9] | 100 ug | Absolute Antibody | ELISA | Human | Request Quotation | Request | ||
| Ab03808-10.0 | Anti-CTLA-4 [11.2.1] | 100 ug | Absolute Antibody | in vivo | Human | Request Quotation | Request | ||
| Ab00511-10.7-BT | Anti-Vaginolysin [9B4] | 1 mg | Absolute Antibody | ELISA; WB; Block | Other | Request Quotation | Request | ||
| Ab03845-23.0-BT | Anti-gp120 protein (CD4-binding domain) [559/64-D] | 1 mg | Absolute Antibody | ELISA; Neutralization; blocking | HIV-1 | Request Quotation | Request | ||
| Ab03836-1.1 | Anti-Severe Fever and Thrombocytopenic Syndrome Virus [MAb4-5] | 100 ug | Absolute Antibody | Cristallography; Neutralizing; SPR; WB | Severe Fever and Thrombocytopenic Syndrome Virus | Request Quotation | Request | ||
| Ab03058-10.29 | Anti-VEGFR2 [IMC-1121B (Ramucirumab)] | 100 ug | Absolute Antibody | FC; IHC; crystallography; in vitro; in vivo; thera | Human | Request Quotation | Request | ||
| Ab00339-1.4 | Anti-VEGF [A.4.6.1] | 200 ug | Absolute Antibody | ELISA; IP; WB; Block; FC; IHC | Human; Rat | Request Quotation | Request | ||
| Ab03786-10.0 | Anti-TGF beta1 [SL15S] | 100 ug | Absolute Antibody | ELISA; Neutralizing | Human | Request Quotation | Request | ||
| Ab01917-1.29 | Anti-USP7 [RAB-C452] | 100 ug | Absolute Antibody | FC; spiked-IP; IP-MS; IF | Human | Request Quotation | Request | ||
| Ab03836-23.0 | Anti-Severe Fever and Thrombocytopenic Syndrome Virus [MAb4-5] | 100 ug | Absolute Antibody | Cristallography; Neutralizing; SPR; WB | Severe Fever and Thrombocytopenic Syndrome Virus | Request Quotation | Request | ||
| Ab03824-10.0 | Anti-4Ig-B7H3 [8H9] | 100 ug | Absolute Antibody | WB; therapeutic; in vivo; IHC; IP | Human | Request Quotation | Request | ||
| Ab03836-23.0-BT | Anti-Severe Fever and Thrombocytopenic Syndrome Virus [MAb4-5] | 1 mg | Absolute Antibody | Cristallography; Neutralizing; SPR; WB | Severe Fever and Thrombocytopenic Syndrome Virus | Request Quotation | Request | ||
| Ab03832-1.1-BT | Anti-MUC1-C/ECD [8E1] | 1 mg | Absolute Antibody | ELISA; WB; FC | Human | Request Quotation | Request | ||
| Ab03840-23.0-BT | Anti-Rotavirus A capsid glycoprotein VP7 [4F8] | 1 mg | Absolute Antibody | Neutralize; ELISA; Crystallization | Other | Request Quotation | Request | ||
| Ab03817-23.0 | Anti-Gn [Mab-3 (32A8-1)] | 100 ug | Absolute Antibody | ELISA; Neutralization; in vivo | Rift Valley fever virus | Request Quotation | Request | ||
| Ab03801-23.0-BT | Anti-VSTM5 [B11] | 1 mg | Absolute Antibody | FC; FACS; ELISA | Human; Mouse | Request Quotation | Request | ||
| Ab00136-1.7 | Anti-V5 epitope tag [SV5-P-K] | 200 ug | Absolute Antibody | ELISA; IF; IHC-Fr; IP; RIA; WB | Paramyxovirus Simian Virus 5 | Request Quotation | Request | ||
| Ab03795-10.0-BT | Anti-APP [2C5] | 1 mg | Absolute Antibody | ELISA; blocking | Human, Mouse | Request Quotation | Request | ||
| Ab03783-1.1 | Anti-Benzopyrene [22F12] | 100 ug | Absolute Antibody | ELISA | Other | Request Quotation | Request | ||
| Ab03806-10.0 | Anti-C3 [C3-2] | 100 ug | Absolute Antibody | ELISA; WB; Inhibition; SPR | Human | Request Quotation | Request | ||
| Ab03801-1.1-BT | Anti-VSTM5 [B11] | 1 mg | Absolute Antibody | FC; FACS; ELISA | Human; Mouse | Request Quotation | Request | ||
| Ab03837-23.0-BT | Anti-Integrin alpha 6 beta 1 [TS2/16] | 1 mg | Absolute Antibody | Cristallography; FC; IP; in vivo; in vitro | Human | Request Quotation | Request | ||
| Ab03819-10.0-BT | Anti-ODC1 [ODC1-2] | 1 mg | Absolute Antibody | WB; IHC; ELISA | Human | Request Quotation | Request | ||
| Ab03829-23.0-BT | Anti-MET [7A2] | 1 mg | Absolute Antibody | SPR; inhibition; ELISA | Human | Request Quotation | Request | ||
| Ab03800-23.0 | Anti-FZD7 [Fab-1791] | 100 ug | Absolute Antibody | WB; in vitro; FC; IHC; blocking | Human | Request Quotation | Request | ||
| Ab03801-10.0 | Anti-VSTM5 [B11] | 100 ug | Absolute Antibody | FC; FACS; ELISA | Human; Mouse | Request Quotation | Request | ||
| Ab03804-1.1 | Anti-PD-1 [Anti-human PD-1 antibody] | 100 ug | Absolute Antibody | ELISA; Blocking; Inhibition | Human | Request Quotation | Request | ||
| Ab03823-23.0 | Anti-Spike protein [3F4] | 100 ug | Absolute Antibody | ELISA | SARS Coronavirus 2 (SARS-Cov-2) | Request Quotation | Request | ||
| Ab03847-1.1 | Anti-Norovirus GII.4 [12A11] | 100 ug | Absolute Antibody | ELISA, blocking | Norovirus | Request Quotation | Request | ||
| Ab03834-23.0-BT | Anti-CD98 [18-2a 7.1] | 1 mg | Absolute Antibody | FACS; SPR | Human | Request Quotation | Request | ||
| Ab03798-1.1 | Anti-PVRIG [334MXX] | 100 ug | Absolute Antibody | FACS | Human | Request Quotation | Request | ||
| Ab00339-10.3-BT | Anti-VEGF [A.4.6.1] | 1 mg | Absolute Antibody | ELISA; IP; WB; Block; FC; IHC | Human; Rat | Request Quotation | Request | ||
| Ab00339-1.4-BT | Anti-VEGF [A.4.6.1] | 1 mg | Absolute Antibody | ELISA; IP; WB; Block; FC; IHC | Human; Rat | Request Quotation | Request | ||
| Ab03517-30.11-BT | Anti-VACV [SC212] | 500 ug | Absolute Antibody | ELISA; in vitro neutralization | Vaccinia virus | Request Quotation | Request | ||
| Ab03806-1.1-BT | Anti-C3 [C3-2] | 1 mg | Absolute Antibody | ELISA; WB; Inhibition; SPR | Human | Request Quotation | Request |